China Universal Asset Management Co., Ltd. Altimmune, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Altimmune, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,081 shares of ALT stock, worth $87,620. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,081Holding current value
$87,620% of portfolio
0.01%Shares
10 transactions
Others Institutions Holding ALT
# of Institutions
207Shares Held
39.5MCall Options Held
1.93MPut Options Held
1.4M-
Black Rock Inc. New York, NY5.32MShares$30.9 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.25MShares$30.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$25.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$20.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$16 Million1.49% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $285M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...